ADICET BIO INC. - COMMON STOCK

Adicet Bio Added to the Russell 2000® Index

28 6 2021 06:00:00 提供 Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

18 5 2021 15:10:00 提供 Nasdaq GlobeNewswire

Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates

17 5 2021 06:01:00 提供 Nasdaq GlobeNewswire

Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit

29 4 2021 06:00:03 提供 Nasdaq GlobeNewswire

Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

15 4 2021 06:00:02 提供 Nasdaq GlobeNewswire

Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research

13 4 2021 06:00:00 提供 Nasdaq GlobeNewswire

Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

11 3 2021 15:10:00 提供 Nasdaq GlobeNewswire

Adicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors

04 3 2021 15:01:00 提供 Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

16 2 2021 06:00:01 提供 Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

11 2 2021 06:00:01 提供 Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

10 2 2021 06:51:22 提供 Nasdaq GlobeNewswire

Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

09 2 2021 15:04:22 提供 Nasdaq GlobeNewswire

Adicet Bio to Participate in Upcoming Investor Conferences

07 1 2021 06:00:00 提供 Nasdaq GlobeNewswire